Journal
PSYCHOPHARMACOLOGY
Volume 163, Issue 3-4, Pages 434-458Publisher
SPRINGER
DOI: 10.1007/s00213-002-1139-6
Keywords
aggression; serotonin; dopamine; GABA; benzodiazepines; SSRI; 5-HT receptor; GABA(A) receptor; alcohol
Categories
Ask authors/readers for more resources
Background and rationale: Aggressive outbursts that result in harm and injury present a major problem for the public health and criminal justice systems, but there are no adequate treatment options. Obstacles at the level of social policy, institutional regulation, and scientific strategy in developing animal models continue to impede the development of specific anti-aggressive agents for emergency and long-term treatments. Objective: To be more relevant to the clinical situation, preclinical aggression research has begun to focus on the neurobiological determinants of escalated aggressive behavior that exceeds species-typical patterns. It is the goal of this review to examine novel pharmacological and molecular tools that target the neural mechanisms for different kinds of aggressive behavior more selectively than previously possible and to outline potential pharmacotherapeutic options.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available